Torque teno virus load predicts opportunistic Infections after kidney transplantation but Is not associated with maintenance immunosuppression exposure
Ver/ Abrir
Registro completo
Mostrar el registro completo DCAutoría
Cañamero, Lucía; Benito-Hernández, Adalberto; González, Elena; Escagedo, Clara; Rodríguez-Vidriales, María; García Saiz, María del Mar; Valero San Cecilio, Rosalía María; Belmar Vega, Lara; Cos Cossio, María de los Ángeles de


Fecha
2023Derechos
Attribution 4.0 International
© 2023 by the authors
Publicado en
Biomedicines, 2023, 11, 1410
Editorial
MDPI AG
Palabras clave
Acute rejection
Immunosuppression
Infection
Kidney transplantation
Monitoring
Torque Teno virus
Resumen/Abstract
Measuring the non-pathogenic Torque Teno Virus (TTV) load allows assessing the net immunosuppressive state after kidney transplantation (KTx). Currently, it is not known how exposure to maintenance immunosuppression affects TTV load. We hypothesized that TTV load is associated with the exposure to mycophenolic acid (MPA) and tacrolimus. We performed a prospective study including 54 consecutive KTx. Blood TTV load was measured by an in-house PCR at months 1 and 3. Together with doses and trough blood levels of tacrolimus and MPA, we calculated the coefficient of variability (CV), time in therapeutic range (TTR) and concentration/dose ratio (C/D) of tacrolimus, and the MPA-area under the curve (AUC-MPA) at the third month. TTV load at the first and third month discriminated those patients at risk of developing opportunistic infections between months 1 and 3 (AUC-ROC 0.723, 95%CI 0.559-0.905, p = 0.023) and between months 3 and 6 (AUC-ROC 0.778, 95%CI 0.599-0.957, p = 0.028), respectively, but not those at risk of acute rejection. TTV load did not relate to mean tacrolimus blood level, CV, TTR, C/D and AUC-MPA. To conclude, although TTV is a useful marker of net immunosuppressive status after KTx, it is not related to exposure to maintenance immunosuppression.
Colecciones a las que pertenece
- D02 Artículos [403]
- D16 Artículos [196]
- D22 Artículos [1093]
- IDIVAL Artículos [864]
Items relacionados
Mostrando ítems relacionados por título, autor, creador y tema.
-
Use of tocilizumab in kidney transplant recipients with COVID-1
Pérez Sáez, María J; Blasco, Miquel; Redondo Pachón, Dolores; Ventura Aguiar, Pedro; Bada Bosch, Teresa; Pérez Florez, Isabel; Melilli, Edoardo; Sánchez Cámara, Luis A; López Oliva, María O; Canal, Cristina; Shabaka, Amir; Garra Moncau, Nuria; Martín Moreno, Paloma L; López, Verónica; Hernández Gallego, Román; Siverio, Orlando; Galeano, Cristina; Espí Reig, Jordi; Cabezas, Carlos J; [et al.] (Wiley Periodicals Inc., 2020) -
Role of targeted therapies in rheumatic patients on COVID-19 outcomes: results from the COVIDSER study
Álvaro Gracia, Jose María; Sanchez-Piedra, Carlos; Manero, Javier; Ruiz-Lucea, María Ester; López-Vives, Laura; Bohorquez, Cristina; Martinez-Barrio, Julia; Bonilla, Gema; Vela, Paloma; García-Villanueva, María Jesús; Navío-Marco, María Teresa; Pavía, Marina; Galindo, María; Erausquin, Celia; González-Gay Mantecón, Miguel Ángel; Rua-Figueroa, Inigo; Pego-Reigosa, Jose M.; Castrejon, Isabel; Sanchez-Costa, Jesús T.; [et al.] (BMJ Publishing Group, 2021)
-
Impact of empirical treatment in extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. bacteremia. A multicentric cohort study
Peralta Fernández, Francisco Galo; Lamelo Otero, María; Álvarez García, Patricia; Velasco Arribas, María; Delgado-Iribarren, Alberto; Horcajada Gallego, Juan Pablo; Montero, María Milagro; Roiz Mesones, María Pía; Fariñas Álvarez, María del Carmen; Alonso Gutiérrez, Juan; Martínez Martínez, Luis
; Gutiérrez Macías, Alfonso; Álava Menica, José Ángel; Rodríguez Guardado, Azucena; Fleites, Ana; Navarro López, Vicente; Sirvent Quílez, Elia; Capdevila Morell, José Antonio (BioMed Central, 2012-10-05)